ArticleESC heart failure2025

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial.

Jerome Roncalli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.